Search

Search Constraints

You searched for: Author/Creator Tammela, Teuvo L.

Search Results

1. Bias‐corrected estimates of effects of PSA screening decisions on the risk of prostate cancer diagnosis and death: Analysis of the Finnish randomized study of screening for prostate cancer. Issue 3 (4th February 2019)

2. Darolutamide and health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: An analysis of the phase III ARAMIS trial. (September 2021)

5. MP27-13 LONG-TERM SAFETY OF DAROLUTAMIDE AMONG PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WHO RECEIVED MORE THAN 4 YEARS OF THERAPY. (May 2022)

6. Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans. (29th May 2015)